4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-20-018222
Options or other derivatives
- Director acquired 95,419 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bright Rex · Director
Table II: Derivative
5 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-03-09 | Grant or award : show line 1 in the form Stock Options | +15,994 | $9.93 | 2024-12-29 | 15,994 | 15,994 | D |
| 2020-03-09 | Grant or award : show line 2 in the form Stock Options | +12,773 | $8.04 | 2027-07-12 | 12,773 | 12,773 | D |
| 2020-03-09 | Grant or award : show line 3 in the form Stock Options | +14,778 | $8.54 | 2028-05-08 | 14,778 | 14,778 | D |
| 2020-03-09 | Grant or award : show line 4 in the form Stock Options | +29,271 | $4.50 | 2029-05-16 | 29,271 | 29,271 | D |
| 2020-03-09 | Grant or award : show line 5 in the form Stock Options | +22,603 | $5.96 | 2030-02-27 | 22,603 | 22,603 | D |
Loading xslF345X03/doc4.xml…